HaTay Pharmaceutical JSC
VN:DHT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
VN |
|
Erie Indemnity Co
F:EI2
|
US |
Intrinsic Value
The intrinsic value of HaTay Pharmaceutical JSC (DHT) under the Base Case is 15 986.52 VND per share. Compared with the current market price of 49 000 VND, the stock appears Overvalued by 67% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What HaTay Pharmaceutical JSC Does
HaTay Pharmaceutical JSC makes and sells finished medicines in Vietnam. Its core business is developing, manufacturing, and distributing prescription drugs, over-the-counter medicines, and some health-related products such as supplements and medical supplies. It sells these products through pharmacies, hospitals, distributors, and other healthcare channels, so the company sits in the middle of the drug supply chain rather than acting as a retailer or clinic.
- Headquarters
- Vietnam VN
- Employees
- 586
- IPO date
- Dec 3, 2008
Revenue & Expenses Breakdown
HaTay Pharmaceutical JSC
Earnings Waterfall
HaTay Pharmaceutical JSC
The intrinsic value for HaTay Pharmaceutical JSC (DHT) under the Base Case is 15 986.52 VND.
Compared with the current market price of 49 000 VND, the stock appears Overvalued by 67% .